4.5 Review

β-Cell Autophagy in Diabetes Pathogenesis

Journal

ENDOCRINOLOGY
Volume 159, Issue 5, Pages 2127-2141

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1210/en.2017-03273

Keywords

-

Funding

  1. National Institute of Diabetes and Digestive and Kidney Diseases [K01DK102492]
  2. Indiana University School of Medicine
  3. Herman B. Wells Center for Pediatric Research

Ask authors/readers for more resources

Nearly 100 years have passed since Frederick Banting and Charles Best first discovered and purified insulin. Their discovery and subsequent improvements revolutionized the treatment of diabetes, and the field continues to move at an ever-faster pace with respect to unique treatments for both type 1 and type 2 diabetes. Despite these advances, we still do not fully understand howapoptosis of the insulin-producing beta-cells is triggered, presenting a challenge in the development of preventative measures. In recent years, the process of autophagy has generated substantial interest in this realm due to discoveries highlighting its clear role in the maintenance of cellular homeostasis. As a result, the number of studies focused on islet and beta-cell autophagy has increased substantially in recent years. In this review, we will discuss what is currently known regarding the role of beta-cell autophagy in type 1 and type 2 diabetes pathogenesis, with an emphasis on new and exciting developments over the past 5 years. Further, we will discuss how these discoveries might be translated into unique treatments in the coming years.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available